DHRUVI PATEL: Open Payments
NPI 1750025276 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 121 payments from 16 companies in 2025. Trend: 2023 $1,012 · 2024 $1,434 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $357 |
| ABBVIE INC. | 21 | $284 |
| Axsome Therapeutics, Inc. | 15 | $258 |
| Neurocrine BioSciences, Inc. | 4 | $208 |
| Vanda Pharmaceuticals Inc. | 16 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $200 |
| Otsuka America Pharmaceutical, Inc. | 12 | $197 |
| E.R. Squibb & Sons, L.L.C. | 7 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Bausch Health US, LLC | 5 | $95 |
Products named: SPRAVATO, VRAYLAR, REXULTI, Auvelity, INGREZZA, CAPLYTA, COBENFY, FANAPT.
Industry payments across NC — which companies pay providers there.
